The executive team at Atea Pharmaceuticals has a history of experience in the pharmaceutical and finance industries. Many on the team have worked for companies such as Idenix Pharmaceuticals, iBio, and Tolerx in positions such as VP, CMC, Sr. VP Finance, and General Counsel/Secretary. The team also has experience in clinical operations, having worked as Sr. Director, Clinical Operations at Alnylam Pharmaceuticals, Sideris Pharmaceuticals, and Idenix Pharmaceuticals. Other members of the team have experience as an Associate Manager, Clinical Monitoring at Averion International, Vice President of Finance at Mersana Therapeutics, Senior Director of Finance at Tolerx, Inc., Accounting Manager at Sonus Networks, Director of Finance and Controller at InfoLibria, and Executive Director, Clinical Pharmacology & Early Medical Development at Idenix Pharmaceuticals. The team is also educated, with members holding degrees from Providence College, Boston College, University of Massachusetts Amherst, and China Pharmaceutical University.
Adel Moussa
EVP, Chemistry
Andrea Corcoran
CFO & EVP, Legal
Arantxa Horga
Chief Medical Officer
Janet Hammond
Chief Development Officer
Jayanthi Wolf
EVP, Regulatory Affairs
Jean-Pierre Sommados...
Founder, Chairman & CEO
John Vavricka
Chief Commercial Officer
Jonae Barnes
SVP, Investor Relations & Corp...
Keith Pietropaolo
SVP, Clinical Sciences
Nancy Agrawal
EVP, Preclinical Development
Steven Good
EVP, Preclinical Science
Wayne Foster
EVP, Chief Accounting Officer
Xiao-Jian Zhou
EVP, Early Stage Development
View all